Michael F. Huang

SLNO

Michael F. Huang serves as officer: Sr. VP of Clinical Development at Soleno Therapeutics, Inc. (SLNO). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$1.25M

Net Position

Net Seller

$1.25M

Companies Traded

SLNO

Active Period

Mar 2025 – Mar 2026

3 total trades

Most Recent

Sell SLNO

Mar 31, 2026 · $200.4K

Michael F. Huang's Insider Trading at Soleno Therapeutics, Inc. (SLNO)

Buys

0 · $0.00

Sells

3 · $1.25M

Total Shares Bought

Total Shares Sold

21,977

SLNO Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 31, 2026	Sell	6,582	$30.44	$200.4K	42,149
Dec 15, 2025	Sell	812	$49.95	$40.6K	0
Mar 27, 2025	Sell	14,583	$69.51	$1.01M	0

Related Insiders

Meredith Manning

officer: Chief Commercial Officer

SLNOSell · Mar 31, 2026

Bhatnagar Anish

CHIEF EXECUTIVE OFFICER

SLNOSell · Dec 15, 2025

James H Mackaness

CHIEF FINANCIAL OFFICER

SLNOSell · Dec 15, 2025

Kristen Yen

SEE REMARKS

SLNOSell · Dec 15, 2025

Patricia C Hirano

SEE REMARKS

SLNOSell · Jul 1, 2025

Explore More Insider Trading Data

SLNO Insider Trading Activity

View all insider trades at Soleno Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity